ArticleThe Journal of clinical investigation2026

TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.

Shahrzad Jalali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.